Evidence map›Paper›PMID 37630183›Full record

ArticleMicromachines2023

Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents.

Vera L Kovalenko, Olga A Kolesnikova, Maxim P Nikitin, Victoria O Shipunova, Elena N Komedchikova

Abstract read
In one paragraph

Article in Micromachines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vera L KovalenkoMoscow Institute of Physics and Technology, 9 Institutskiy per., 141701 Dolgoprudny, Russia.
Olga A KolesnikovaMoscow Institute of Physics and Technology, 9 Institutskiy per., 141701 Dolgoprudny, Russia.
Maxim P NikitinMoscow Institute of Physics and Technology, 9 Institutskiy per., 141701 Dolgoprudny, Russia.
Victoria O ShipunovaMoscow Institute of Physics and Technology, 9 Institutskiy per., 141701 Dolgoprudny, Russia.ORCID 0000-0001-6361-1042
Elena N KomedchikovaMoscow Institute of Physics and Technology, 9 Institutskiy per., 141701 Dolgoprudny, Russia.ORCID 0000-0002-5115-3774

Funding

MSHE of RF agreement 075-03-2023-106, project FSMG-2023-0015Russian Science Foundation 22-73-10141
6 · The paper itself

Abstract

Photothermal therapy is one of the most promising and rapidly developing fields in modern oncology due to its high efficiency, localized action, and minimal invasiveness. Polymeric nanoparticles (NPs) incorporating low molecular-weight photothermal dyes are capable of delivering therapeutic agents to the tumor site, releasing them in a controlled manner, and providing tumor treatment under external light irradiation. The nanoparticle synthesis components are critically important factors that influence the therapeutically significant characteristics of polymeric NPs. Here, we show the impact of stabilizers and solvents used for synthesis on the properties of PLGA NPs for photothermal therapy. We synthesized PLGA nanocarriers using the microemulsion method and varied the nature of the solvent and the concentration of the stabilizer-namely, chitosan oligosaccharide lactate. A phthalocyanine-based photosensitizer, which absorbs light in the NIR window, was encapsulated in the PLGA NPs. When mQ water was used as a solvent and chitosan oligosaccharide lactate was used at a concentration of 1 g/L, the PLGA NPs exhibited highly promising photothermal properties. The final composite of the nanocarriers demonstrated photoinduced cytotoxicity against EMT6/P cells under NIR laser irradiation in vitro and was suitable for bioimaging.

Indexed as

magnesium(II) phthalocyaninephotothermal therapyPLGApolymeric nanoparticleswater-in-oil method

Identifiers

PMID37630183
PMCPMC10458446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.